Some plasma ceramide levels were observed to be up-regulated with the disease shifting direction as SCAD, UA, and MI and positively correlated with atherosclerosis burden quantified by the SYNTAX score and SYNTAX score II and the evidence of subclinical myonecrosis quantified by cTnI. This evidence concerns the gene TNNI3 and atherosclerosis.